Increased Expression of MCT4 and GLUT-1 in Early Events of Spheroid Formation of Adenocarcinomic Epithelial Cells A549 by Alföldi, Róbert et al.
 Advances in Drug Discovery and Development, 2016, 9-15 9 
 
  © 2016 Advances in Drug Discovery and Development 
Increased Expression of MCT4 and GLUT-1 in Early Events of Spheroid  
Formation of Adenocarcinomic Epithelial Cells A549 
Róbert Alföldi, Liliána Z. Fehér, Gábor J. Szebeni and László G. Puskás* 
Avidin Ltd., Alsó Kikötő Sor 11., Szeged, Hungary 
Abstract: Monolayer cell cultures (2D) cannot adequately represent the growth and microenvironment 
conditions of three-dimensional (3D) tumors, resulting in false interpretation of molecular events and re-
sponses to chemotherapeutic interventions of solid tumors in vivo. Anaerobic conditions within an expand-
ing spheroid, similar to in vivo conditions, cells are competing for nutrients and oxygen resulting in activated 
expression of metabolic enzymes in order to ensure an adequate supply of energy for cell proliferation. On 
the other hand cells growing in 2D cultures no such competition and no selective pressure exist. Therefore, 
in vitro multicellular tumor spheroid models provide a more reliable tool for drug screening and target identi-
fication. We established a screening strategy where small spheroids of A549 adenocarcinomic epithelial 
cells are studied. Induction of ITGA6 a marker in cellular polarity in 3D cultures could not be confirmed in 
our early formed spheroids. When these small colonies of cells are propagated under levitating conditions, 
nutrient and oxygen limitation is not relevant, therefore hypoxic induction of transcription machinery has not 
been initiated. We found that expression of genes coding for glycolytic enzymes PGK1, ALDOA1 and 
LDHA, some of the main indicators of cancer glycolytic pathway, was not changed significantly. In contrast, 
elevation of lactate transporter MCT4 and glucose transporter GLUT1 mRNA could be detected in 3D 
propagated cells. Interestingly, the other type of lactate transporter, MCT-1 expression was unaltered, 
therefore specific inhibition of MCT4 might prevent spheroid formation and growth. Our strategy for screen-
ing novel targets of early events of spheroid formation might identify proteins that may be promising phar-
macological targets for cancer chemotherapy. 
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INTRODUCTION 
Monolayer cell cultures cannot adequately repre-
sent some aspects of the growth and microenvi-
ronment conditions of three-dimensional solid tu-
mors, resulting in different responses to chemo-
therapeutic interventions. Therefore, in vitro mod-
els of multicellular 3D tumor spheroids provide an 
important tool for drug screening and target identi-
fication. On the other hand, experiments on ani-
mal models are time consuming, costly and not 
reasonable for high throughput screening studies. 
Therefore, in vitro models of multicellular tumor 
spheroids provide an important link between two-
dimensional cell cultures and animal experiments 
[1-3]. 
The functional genomics studies using high 
throughput methods, such as microarrays, enable 
us to identify cancer-specific markers that can be 
utilized in diagnostics or in developing novel ther-
apies [4-5]. During chemical genomics approaches, 
the integration of cell-based assays with activity/ 
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affinity-based approaches allows to interrogate 
the cells by analyzing phenotypic alterations, 
changes of transcript signature or detecting the 
differences in protein expression levels [6]. These 
approaches enable the investigator to obtain nov-
el, therapeutically relevant targets as well as drug 
candidates in a target- or pathway-specific man-
ner. However, when these studies are performed 
on 2D cell cultures gene, protein or phenotypic 
changes cannot adequately reflect the data ob-
tained with solid tumors. By using DNA microarray 
technology Ernst et al. confirmed that gene ex-
pression changes in spheroid cultures closely re-
sembled those detected in primary glioblastoma 
stem cell-like tumors obtained from patients, while 
genomic changes in monolayer cultures did not 
match well with the respective primary tumors [7]. 
Several studies have been published on applying 
cancer spheroids for screening and target identifi-
cation [7-11], however, in these studies the sub-
jects of investigations were the bigger spheroids 
that represent similar restricted conditions for the 
inner part of the spheroid cells to in vivo condi-
tions. In those cells oxygen and nutrient depriva-
tion result in anaerobic conditions, induced glyco-
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lytic enzymatic activities, elevated autophagy and 
necrosis [12-15]. 
In our study we intended to focus on the early 
events of colony formation in order to obtain more 
information on key genes that are responsible for 
metabolic switch and to better understand the ear-
ly events of multicellular tumor formation. 
MATHERIALS AND METHODS 
Cell Line 
The NSCLC cell line A549 (adenocarcinomic hu-
man alveolar basal epithelial cells) was purchased 
from the ATCC collection and maintained in sug-
gested medium in a humidified atmosphere of 
95% air and 5% CO2. 
2D Cell Culture 
The A549 cancer cells were maintained in 
DMEM/F12 (DMEM, PANTM Biotech; F12 Nut mix, 
Gibco, Life Technologies) containing 4,5 g/L 
glucose and 10% fetal bovine serum (FBS, Gibco, 
Life Technologies), 1xGlutaMAXTM (Gibco, Life 
Technologies) 1% PenStrep antibiotics (Penicillin 
G sodium salt, and Streptomycin sulfate salt, Sig-
ma-Aldrich Co.). The cells were cultured in Tissue 
Culture T-75 flasks (Corning) reaching 70-80% 
confluence at standard atmosphere of 95% air 
and 5% CO2. At about 70-80% confluence, cells 
were washed, harvested with collagenase and 
seeded into new T-75 flasks. Two independent 
experiments were conducted starting from differ-
ent seeding cell numbers. Cells were harvested 
and analyzed after 2 and 4 days of incubation. 
3D Cell Culture Using Bench-Top Incuba-
tor System 
A549 cancer cells were cultured in specially de-
signed LeviTubesTM in the bench top bioreactor-
incubator hybrid (BioLevitatorTM, Hamilton). During 
the cultivation, cells were proliferated in suspen-
sion culture without microcarriers with the follow-
ing protocol: Inoculation period: Rotation Pause: 0 
s, Rotation Period: 1 s, Agitation Pause: 20 min, 
Rotation Speed: 50 rpm, Agitation Period: 5 min, 
Duration: 5h. Culture period: Rotation Pause 0 s, 
Rotation Period: 1 s, Rotation Speed: 75 rpm, Du-
ration: ∞. 
LeviTubesTM contained 40 ml media. Culture me-
dium was changed once after 48 hour by remov-
ing half of the volume of original culture medium 
and replacing it with fresh media. Cells were col-
lected by centrifugation at 3000 rpm at 4 oC for 10 
min after 4 days rotation in the LeviTubesTM. 
Resazurin Viability Assay 
The viability of A549 cells grown under 2D culture 
conditions, as well as the ones grown as sphe-
roids in the Levitubes (Hamilton) was determined 
every day by the fluorescent resazurin (Sigma-
Aldrich) assay. Resazurin reagent was dissolved 
in PBS (pH 7.4) at 0.15 mg/ml concentration, 0.22 
µM filtered and aliquoted and stored at -20°C. Af-
ter 2 hours incubation of cells with resazurin at 
37°C, fluorescence was recorded (530 nm excita-
tion / 580 nm emission) on a multimode micro-
plate reader (Cytofluor4000, PerSeptive Bio-
sytems). The relative growing kinetics was calcu-
lated by normalization to values obtained at day 0. 
Nucleic Acid Isolation 
RNA from 2D cell culture and spheroids was puri-
fied as described previously [16]. Briefly: columns 
and washing buffer were from Bioneer (Viral RNA 
extraction kit, Daejon, South Korea). Cells were 
washed with PBS, incubated in lysis buffer (RA1; 
Macherey-Nagel, Düren, Germany). The lysate 
was collected and mixed with 70% ethanol in 
RNase-free water (Bioneer). The mixture was 
transferred through columns. The columns were 
washed with 350 µl of 80% ethanol in diethylpyro-
carbonate- (DEPC)-treated water. Then 95 µl 
DNase reaction mixture (Macherey Nagel, Düren, 
Germany) was loaded onto the columns and were 
incubated at room temperature for 15 min. After 
the DNase digestion, the columns were washed 
with 150 µl mixture of RA1 lysis buffer (Macherey-
Nagel) and ethanol, 600 µl and 300 µl W2 wash-
ing buffer. The total RNA was eluted in 50 µl 
RNase free-water. One µl RNase inhibitor (Ap-
plied Biosystems, Foster City, CA, USA) was add-
ed to the samples. The quality and quantity of the 
isolated RNA were measured with NanoDrop1000 
Version 3.8.1. (Thermo Scientific). 
We started two and three replicates in monolayer 
cultures in the first and second experiments, 
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respectively. We started two replicates in 3D 
cultures both in the first and second experiments 
for nucleic acid isolation and subsequent gene 
expression analysis. 
Gene Expression Analysis 
Gene expression analysis was performed on 
cDNA converted from total RNA as described pre-
viously [17]. Briefly, reverse transcription from 3 
µg total RNA in 30 µl was performed with the High 
Capacity cDNA Archive Kit according to the manu-
facturer’s protocol (Applied Biosystems). cDNA 
was diluted to 80 µl. Gene expression was meas-
ured with gene-specific primers with SybrGreen 
protocol on a LightCycler® Nano Instrument 
(Roche). For cycling each 10 µl PCR reaction con-
tained 20 ng cDNA, 5 µl FastStart Essential DNA 
Green Master (2x) (Roche), the corresponding 
primer set and the Setup Control. The primer se-
quences are listed in Table 1. The PCR protocol 
was as follows: enzyme activation at 95 °C for 10 
min, 50 cycles of denaturation at 95 °C for 15 sec, 
and annealing and extension at 60 °C for 30 sec. 
A total of 12 gene-specific assays were run on five 
independent samples from 2D condition and four 
independent samples from 3D conditions. Gene 
expression was normalized to the average values 
of beta actin (ACTB), glyceraldehyde-3-phosphate-
dehydrogenase (GAPDH), and hypoxanthine 
phosphoribosyl transferase 1 (HPRT1) expression 
as endogenous controls and expressed relative to 
the average values of 2D cell culture controls (du-
plicates in the first experiment and triplicates in 
the second) by using the 2-ΔΔCt method. Statistical 
analysis were performed using GraphPad Prism 6. 
Data were expressed as mean ± standard devia-
tion (STD). 
RESULTS 
Cell Cultures 
A549 cells were cultured using culture flask to ob-
tain cells grown under 2D conditions. These cells 
served as controls for comparison of cells from 2D 
and spheroid cultures. To analyze whether differ-
ent incubation times affect gene expression 
changes in 2D cultures 2 and 4 days incubation 
periods were applied in two independent experi- 
ments starting from the same seeding cell num-
bers. After reaching app. 70% confluency (Figure 
1A) cells were harvested for RNA preparation and 
subsequent gene expression study. Spheroid for-
mation was performed in a special instrument, the 
BiolevitatorTM system, where cells were levitated 
for 4 days. The cultivation of 2D and 3D cells were 
performed under the same conditions (cell culture 
media, glucose concentration, pH, pCO2, pO2). 
After 4 days levitation small spheroids consisting 
of 20-40 cells formed (Figure 1B). To minimize 
Table 1: Primers Used in This Study 
Gene 
symbol Product Acc. No. Forward primer Reverse primer
Amplicon 
length
MMP9 matrix metallopeptidase 9 BC006093.1 gaaccaatctcaccgacagg agggacagttgcttctggag 133
HIF1a hypoxia inducible factor 1, alpha AF304431.1 tcaagcagtaggaattggaaca gtgatgtagtagctgcatgatcg 62
PGK1 phosphoglycerate kinase 1 BC113568.1 gcccagaagtggagaaagc cacatgaaagcggaggttc 77
LDHA lactate dehydrogenase A NM_005566.3 gcagatttggcagagagtataatg gacatcatcctttattccgtaaaga 93
MCT-1 solute carrier family 16, member 1 XM_005271150.1 gtgaccattgtggaatgctgt catgtcattgagccgaccta 66
MCT-4 solute carrier family 16, member 3 BC112267.1 gctcacctcctccctgattt tttgggcttcttcctaatgc 61
MMP2 matrix metalloproteinase 2 NM_004530.4 tgtgttctttgcagggaatg ggtcagtggcttggggta 76
ENO1 enolase 1 M14328.1 ccttcatcaaggactacccagt tcccccactacctggattc 109
ALDOA aldolase A, fructose-bisphosphate M11560.1 aagtacactccgagcggtca ggcgtggttagagacgaaga 66
GLUT1 solute carrier family 2, member 1 BC118590.1 ccccatcccatggttcatc tgaggtccagttggagaagc 91
ITGA6 integrin alpha 6 BC058095.1 tcagtattcaggagtagcttggtg atcagaatcccggcaagaa 60
TRXR1 thioredoxin reductase 1 NM_003330.3 ggcgatatattggaggataagg atagagcctctgagccagca 60
HPRT hypoxanthine phosphoribosyltransf. 1 NM_000194.2 tgaccttgatttattttgcatacc cgagcaagacgttcagtcct 102
ACTB beta actin BC002409.2 attggcaatgagcggttc cgtggatgccacaggact 79
GAPDH glyceraldehyde-3-phosphate dehydr. BC025925.1 agccacatcgctgagaca gcccaatacgaccaaatcc 66  
 
12     Advances in Drug Discovery and Development, 2016 Alföldi et al. 
false positive and negative results spheroid culti-
vation was performed in two independent studies 
and 2 parallel samples were analyzed in each 
study. Spheroids were collected by centrifugation 
and after RNA purification and cDNA preparation 
gene expression analysis was conducted. 
Functional difference between cells grown under 
2D and 3D conditions was confirmed by analyzing 
their proliferation rate determined with the resaz-
urin assay. While exponential proliferation could 
be detected in the 2D culture we found decreased 
proliferation of 3D cells in the course of the exper-
iment (Figure 2). At day 4, when the gene expres-
sion analysis was done three times less cells 
could be detected in the spheroids comparing to 
cells grown in 2D. 
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Figure 2: Proliferation rate of A549 cells grown under 
2D (blue) and 3D (purple) conditions. 
Gene Expression Analysis of 2D and Early 
3D Cultures 
Quantitative real-time PCR (QRT-PCR) was used 
to assess the expression of several genes in-
volved in cancer metabolism (lactate dehydrogen-
ase-A, LDHA; phosphoglycerate kinase 1, PGK1; 
lactate transporters MCT1 and MCT2; glucose 
transporter 1, GLUT1; enolase 1, ENO1 and al-
dolase, fructose-bisphosphate A, ALDOA), inva-
sion (matrix metalloproteinase 2, MMP2 and ma-
trix metalloproteinase 9, MMP9), cell surface ad-
hesion (integrin subunit alpha 6, ITGA6) and oxi-
dative stress (hypoxia inducible factor 1, alpha 
subunit, HIF1a and thioredoxin reductase-1, 
TRXR1). 
Gene expression of these selected genes in sphe-
roids was compared to that of 2D cells. Expres-
sion values were normalized to the average val-
ues of beta actin (ACTB), glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH), and hypo-
xanthine phosphoribosyl transferase 1 (HPRT1) 
expression as endogenous controls and ex-
pressed relative to the average of the 2D cell cul-
ture controls. Differential gene expression analy-
sis revealed that among the analyzed genes, in-
duction of lactate transporter MCT4 and glucose 
transporter GLUT1 genes was observed (Figure 
3). As a positive control, ITGA6, a cell polarization 
marker was used, as its significance in 3D cul-
tures have already been proposed [18]. The most 
significant induction could be detected in case of 
MCT4, while interestingly the expression level of 
 
Figure 1: Two-dimensional (A) and spheroid (B) cell culture of A549 adenocarcinomic epithelial cells. 
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the other type of lactate transporter, MCT-1 was 
unaltered. 
DISCUSSION 
During tumor spheroid growth, oxygen and nutri-
ent gradients develop, inducing specific genetic 
and metabolic changes in the proliferative and 
quiescent cellular layers. In our study we focused 
on the early events of colony formation in order to 
obtain more information on key genes that are re-
sponsible for metabolic switch and to better un-
derstand the early events of multicellular tumor 
formation. 
Increased rates of glycolysis, including elevation 
of lactate dehydrogenase-A (LDHA) activity, are 
thought to be one of the hallmarks of tumor cells, 
which unlike normal cells, are able to produce lac-
tate aerobically, a phenomenon known as the 
Warburg effect [20-21]. LDHA is a direct c-Myc-
responsive gene that is involved in Myc-mediated 
cell transformation [22], and reduction of LDHA 
levels abrogates spheroid formation of c-Myc-
transformed cells. It was hypothesized that the 
anaerobic conditions within an expanding sphe-
roid colony of cells competing for nutrients and 
oxygen may select for cells with activated expres-
sion of metabolic enzymes such as LDHA to en-
sure an adequate supply of energy for cell prolif-
eration [23]. Here we show that during the early 
phase of colony formation, under levitating condi-
tions where nutrient and oxygen limitation is not 
relevant, LDHA expression was not altered.  
Previously, it was shown that type VII collagen 
positively regulates the expression of ITGA6, a 
marker playing a role in cellular polarity in 3D 
spheroid keratinocyte cultures [18]. Other studies 
showed that silencing integrin α6 expression de-
creased the metastasis potential of hepatocellular 
carcinoma cells [24] and the loss of A6B4 expres-
sion inhibited colony formation of breast cancer 
cells in soft agar assays [25]. These results impli-
cated a functional role for integrin α6 in anchor-
age-independent growth and in spheroid for-
mation of cancer cells. In our study we found no 
change in ITGA6 expression under our experi-
mental conditions indicating that cell polarization 
has not started yet in the early phase of 3D for-
mation of lung adenocarcinomic epithelial cells. 
Tumor cells produce large quantities of lactic acid 
via glycolysis. Monocarboxylate transporters 
(MCTs) are therefore commonly up-regulated in 
human malignancies to mediate lactic acid efflux. 
In our study, in the early phase of spheroid for-
mation the induction of lactate transporter MCT4 
and glucose transporter GLUT1 genes was ob-
served. Monocarboxylate transporters (MCTs), also 
called the solute carrier family 16 (SLC16), espe-
cially MCT1 (SLC16A1) and MCT4 (SLC16A3) are 
crucial in regulating lactate entry or export through 
the plasma membrane and in decreasing high in-
tracellular lactate levels resulting from glycolytic 
activity of cancer cells and/or cancer associated 
fibroblasts [26-28]. Of particular importance is the 
MM
P9
HI
F1
a
PG
K1
LD
HA
MC
T1
MC
T4
MM
P2
EN
O1
 
AL
DO
A
GL
UT
1
ITG
A6
TR
XR
1
HP
RT
AC
TB
GA
PD
H
G
en
e
ex
pr
es
si
on
ch
an
ge
s
(L
og
2)
-­‐1.0
-­‐0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
*
*
 
Figure 3: Differential gene expression analysis of two-dimensional (A) and spheroid (B) cell culture of A549 adeno-
carcinomic epithelial cells by using QRT-PCR technique. Gene expression changes are expressed as Log2 values. 
*denotes for significance p<0.05 as calculated by T-test. 
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upregulation of MCT4 expression in response to 
hypoxia, which is mediated by hypoxia inducible 
factor 1α (HIF1A) [29]. Malignant cells obtain their 
energy needs through increased glucose con-
sumption, therefore tumor cells exhibit elevated 
levels of glucose uptake mediated by GLUT1, 
which is the key rate-limiting step in glucose utili-
zation. GLUT1 expression is increased in various 
cancers [30-31]. This phenomenon has been used 
for diagnostic imaging in a wide variety of cancers 
with radio-labeled glucose analogs [32]. 
We hypothesize that MCT4 and GLUT1 induction 
precede the induction of other glycolytic genes 
and represents the first steps of reprogramming of 
tumor cells preparing them for 3D growth and al-
tered metabolism. 
Here we presented a novel screening platform 
where small spheroids levitating in oxygen and 
nutrient rich culture media were the subject of gene 
expression investigations. Global gene expression 
screening, as well as studies on proteome and 
metabolome of the small spheroids, might result in 
novel targets for cancer chemotherapy. 
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